We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
Cap. Flow
+$505M
Cap. Flow %
0.65%
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$83.5M
2
SPGI icon
S&P Global
SPGI
+$73.5M
3
TSLA icon
Tesla
TSLA
+$55.8M
4
MSFT icon
Microsoft
MSFT
+$45.9M
5
AMZN icon
Amazon
AMZN
+$27.9M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 13.53%
3 Healthcare 13.01%
4 Consumer Discretionary 11.66%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSUR icon
1976
OraSure Technologies
OSUR
$276M
$1.42M ﹤0.01%
209,297
+240
+0.1% +$1.92K
SCS
1977
DELISTED
Steelcase
SCS
$1.42M ﹤0.01%
118,577
-15,521
-12% -$188K
XRN
1978
Chiron Real Estate Inc
XRN
$472M
$1.42M ﹤0.01%
17,341
-71
-0.4% -$5.81K
AGNT
1979
AGNT Inc
AGNT
$697M
$1.41M ﹤0.01%
66,727
+2,380
+4% +$62.3K
SRG
1980
Seritage Growth Properties
SRG
$136M
$1.41M ﹤0.01%
111,600
-10,620
-9% -$117K
ONEM
1981
DELISTED
1Life Healthcare
ONEM
$1.41M ﹤0.01%
127,469
+3,448
+3% +$38.6K
STEP icon
1982
StepStone Group
STEP
$3.82B
$1.41M ﹤0.01%
42,627
+4,641
+12% +$160K
RXDX
1983
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$1.4M ﹤0.01%
37,177
+1,226
+3% +$48.5K
PRO
1984
DELISTED
PROS Holdings
PRO
$1.4M ﹤0.01%
42,130
-107
-0.3% -$3.29K
NIC icon
1985
Nicolet Bankshares
NIC
$3.61B
$1.4M ﹤0.01%
14,983
-1,062
-7% -$99K
SAGE
1986
DELISTED
Sage Therapeutics
SAGE
$1.4M ﹤0.01%
42,324
-5,524
-12% -$208K
AGM icon
1987
Federal Agricultural Mortgage
AGM
$2.54B
$1.4M ﹤0.01%
12,873
-1,569
-11% -$192K
ITOS
1988
DELISTED
iTeos Therapeutics
ITOS
$1.4M ﹤0.01%
43,373
+16,099
+59% +$585K
COIN icon
1989
Coinbase
COIN
$39.2B
$1.4M ﹤0.01%
7,350
-247
-3% -$48.3K
RTL
1990
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$1.39M ﹤0.01%
176,182
-11,548
-6% -$93.5K
CIR
1991
DELISTED
CIRCOR International, Inc
CIR
$1.39M ﹤0.01%
52,271
+2,648
+5% +$70.2K
HCAT icon
1992
Health Catalyst
HCAT
$129M
$1.39M ﹤0.01%
53,189
+4,094
+8% +$116K
FIGS icon
1993
FIGS
FIGS
$2.39B
$1.39M ﹤0.01%
64,531
-19,085
-23% -$380K
EDIT icon
1994
Editas Medicine
EDIT
$435M
$1.38M ﹤0.01%
72,545
+576
+0.8% +$10.7K
SHLS icon
1995
Shoals Technologies Group
SHLS
$1.44B
$1.38M ﹤0.01%
80,727
-11,235
-12% -$195K
DOUG icon
1996
Douglas Elliman
DOUG
$166M
$1.37M ﹤0.01%
197,189
+38,622
+24% +$293K
PHR icon
1997
Phreesia
PHR
$765M
$1.37M ﹤0.01%
52,028
+3,528
+7% +$108K
PNTG icon
1998
Pennant Group
PNTG
$1.39B
$1.37M ﹤0.01%
73,521
+5,613
+8% +$93.7K
OSG
1999
Octave Specialty Group
OSG
$210M
$1.37M ﹤0.01%
131,313
-458
-0.3% -$6.21K
MRC
2000
DELISTED
MRC Global
MRC
$1.36M ﹤0.01%
114,648
-13,279
-10% -$124K

Similar funds

RhumbLine Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
  • RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
  • RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
  • RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
  • RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
  • RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.